Dexcom | Des Atouts



Assets Changement Date
Abbott USD 81.45B 34M 2025-03
Align Technology USD 6.1B 111.78M 2025-03
AtriCure USD 591.63M 17.7M 2025-03
Avanos Medical USD 1.11B 46.4M 2025-03
Baxter International USD 25.78B 894M 2024-12
Becton, Dickinson and Co. USD 54.47B 198M 2025-03
Boston Scientific USD 40.14B 745M 2025-03
Cooper Companies USD 12.22B 93M 2025-01
Dexcom USD 6.75B 267.2M 2025-03
Edwards Lifesciences USD 13.06B 84.1M 2024-12
Globus Medical USD 4.71B 540.6M 2025-03
Hologic USD 8.55B 183.6M 2025-03
Insulet USD 3.52B 429.6M 2025-03
Integra LifeSciences USD 4.05B 15.33M 2025-03
J&J USD 193.67B 13.57B 2025-03
Masimo USD 2.29B 332.6M 2025-03
Medtronic USD 91.68B 1.71B 2025-04
Merit Medical Systems USD 2.47B 49.37M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Solventum Corp 14.53B 70M 2025-03
Stryker USD 46.01B 3.04B 2025-03
Tandem Diabetes Care USD 922.14M 45.52M 2025-03
Teleflex USD 7.16B 65.38M 2025-03
West Pharmaceutical Services USD 3.62B 25.2M 2025-03
Zimmer Biomet Holdings USD 21.37B 355M 2024-12



Dexcom Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.